Disulfide-and Thiol-Containing Oligonucleotides
The starting oligonucleotide, bearing a disulfide or thiol group at the 3′ or 5′ terminus, can be purchased (e.g., Integrated DNA Technologies, Sigma-Genosys) or synthesized in the laboratory. If the oligonucleotide is purchased, it is extremely important that the product be purified from other thiols, such as dithiothreitol (DTT) or dithioerythritol (DTE), which are sometimes added as stabilizers. This can be achieved via size-exclusion chromatography, HPLC, or preparative gel electrophoresis (e.g., CPMB UNIT 2.5A).
If the oligonucleotide is synthesized on a DNA synthesizer (e.g., APPENDIX 3C) using the phosphoramidite method (UNIT 3.3) , a disulfide functionality may be generated in a number of ways. 3′-Disulfide-containing oligonucleotides can be synthesized by beginning with a 3′-thiol modifier controlled-pore glass (CPG) or by beginning with a universal support CPG and adding a disulfide modifier phosphoramidite as the first monomer in the sequence. 5′-Disulfide-containing oligonucleotides can be synthesized by ending the synthesis with a disulfide modifier phosphoramidite. In all cases, the 4,4′-dimethoxytrityl protecting group should be removed from the 5′-hydroxy terminus under acidic conditions (80% acetic acid for 30 min; UNIT 10.5) before conjugation of the DNA to the particles. Oligonucleotide synthesis reagents are available from a number of suppliers (e.g., Glen Research, TriLink BioTechnologies, ChemGenes).
Oligonucleotides with a free 5′-thiol can also be generated by ending the synthesis with a 5′-tritylthiol modifier phosphoramidite, and these oligonucleotides can be conjugated to particles (Storhoff et al., 1998) . However, this protocol requires that the 4,4′-dimethoxytrityl protecting group be removed from the thiol before conjugation. This deprotection procedure is described in Storhoff et al. (1998) and can be found at the Glen Research Web site (http://www.glenresearch.com/ProductFiles/Technical/ tech_questions.html#44). In addition, because free thiol groups are not stable to prolonged storage, the strands should be used immediately after deprotection.
BASIC PROTOCOL 1

PREPARATION OF GOLD NANOPARTICLE-DNA CONJUGATES CONTAINING ONE TO SEVERAL DNA STRANDS PER PARTICLE
This protocol describes the synthesis and isolation of gold nanoparticles with one to several synthetic oligodeoxyribonucleotides attached. The synthetic oligonucleotide must be modified to contain a thiol or disulfide group to attach the strand to the gold surface of the particle. A strong, covalent Au-S bond is formed spontaneously between the nanoparticles and DNA by simply mixing the two components. In practice, this procedure generates particles with a statistically distributed number of oligonucleotides attached to each particle; particles with a single attached oligonucleotide can be separated from unmodified and multiply modified particles by preparative horizontal gel electrophoresis. The protocol works best for nanoparticles with diameters between 5 and 20 nm. The resulting DNA-particle conjugates can then be characterized by UV/visible spectroscopy.
Materials
Oligonucleotide: ∼l mM synthetic 5′-or 3′-disulfide-containing or thiol-containing oligonucleotide (see Strategic Planning), dissolved in water Aqueous gold nanoparticle solution (British Biocell, Ted Pella; or (Breslauer et al., 1986; Sugimoto et al., 1996) . See also UNIT 7.3. Quantitate nanoparticle solution 4. Using the spectrophotometer, measure the A 520 of an aliquot of an aqueous gold nanoparticle solution. If the measured absorbance is >1, dilute the aliquot by increments of ten with water until the absorbance is <1.
If the nanoparticles are purchased, the supplier may also include a measured concentration of the particle solution, and steps 4 and 5 can be skipped.
5. Estimate the concentration of the nanoparticle solution (c n in M), again using Beer's Law:
where ε n is the molar extinction coefficient of the nanoparticle at 520 nm and d is the dilution factor used in step 4.
Estimated values for ε n are sufficient for this protocol and can be obtained from Complex nanoparticles with phosphine 6. To 10 mL gold nanoparticle solution, add 2 mg phosphine (final 0.5 M). Rotate this solution 10 hr at room temperature on an orbital shaker at low speed. 7. Add solid NaCl until the solution turns from deep burgundy to a lighter purple color (usually at ∼2 to 3 M NaCl).
8. Centrifuge the particle solution 30 min at 500 × g, room temperature, to pellet the particles.
9. Discard supernatant and resuspend particles in 1 mL of 0.5 mM phosphine.
10. Add 0.5 mL methanol to precipitate the particles and centrifuge again 30 min at 500 × g, room temperature. 11. Discard supernatant and resuspend particles in 1 mL of 0.5 mM phosphine.
12. Add 110 µL of 5× TBE electrophoresis buffer to this solution (0.5× TBE final).
13. Repeat steps 4 and 5 to determine the concentration of this nanoparticle solution.
14. Calculate the number of moles of nanoparticles in the solution by multiplying this concentration by the solution volume (1.1 mL).
Conjugate nanoparticles and oligonucleotide
15. Dilute an aliquot of disulfide-functionalized oligonucleotide solution containing 0.9 mol eq DNA (relative to moles of nanoparticle in step 14) in enough 0.5× TBE to make the solution 50 µM in oligonucleotide.
16. Combine the oligonucleotide and nanoparticle solutions and mix well.
17. Add 0.05 vol of 1 M NaCl to bring the solution to 50 mM NaCl. Place the solution on an orbital shaker at low speed (<1 Hz) and incubate 16 hr at room temperature.
Purify conjugates
18. Add 0.2 vol of 30% glycerol (5% final) to the conjugate mixture.
19. Load aliquots of this solution into alternating wells of a horizontal agarose gel in 0.5× TBE. Also load a gel standard, prepared by diluting 20 µL unmodified particles (step 12) with 4 µL of 30% glycerol. 22. Insert a piece of glass-fiber filter paper and a strip of dialysis membrane into the slit, with the filter paper facing the band.
The pink color of the band is easily visualized as it transfers from the gel to the filter paper.
23. Return the gel tray to the electrophoresis apparatus and electrophorese at 15 V/cm until the band has electroeluted into the paper.
24. Remove the filter paper and dialysis membrane together from the gel and place them, filter paper face down, into a 0.45-µm centrifugal filter device.
25. Add 250 µL of 0.5× TBE to the device and centrifuge 3 min at 14,000 × g, room temperature (according to manufacturer's instructions), to elute the particles into the device receiver.
Quantitate and store conjugates 26. Repeat steps 4 and 5 to determine the concentration of particle conjugates. 
PREPARATION OF GOLD NANOPARTICLE-DNA CONJUGATES CONTAINING MANY DNA STRANDS PER PARTICLE
This protocol describes the synthesis and isolation of gold nanoparticles with a layer of many synthetic oligodeoxyribonucleotides attached. The number of oligonucleotides attached can vary widely; for a detailed discussion of this topic, see Background Information. As in Basic Protocol 1, each oligonucleotide is bound to the particle surface by a strong, covalent Au-S bond. However, the dense oligonucleotide layer formed in these conjugates obviates the need for a protective shell of anionic phosphine ligands. Also, because of the large number of oligonucleotides attached to each particle, it is not possible to separate nanoparticles bearing slightly different numbers of oligonucleotides from each other. As a result, the DNA-particle conjugates can be isolated from free, unreacted thiol-oligonucleotides by centrifugation and characterized by UV/visible spectroscopy.
Materials
Oligonucleotide: ∼1 mM synthetic 5′-or 3′-disulfide-containing or thiol-containing oligonucleotide (see Strategic Planning), dissolved in water Aqueous gold nanoparticle solution (British Biocell or see Support Protocol) 1 M NaCl 0.1 M sodium phosphate buffer, pH 7 (APPENDIX 2A) 0.1 M NaCl/10 mM sodium phosphate buffer, pH 7 0.3 M NaCl/0.01% (w/v) sodium azide/10 mM sodium phosphate buffer, pH 7
Additional reagents and equipment for quantitating oligonucleotide, nanoparticle, and conjugate solutions (see Basic Protocol 1) Calculate amount of oligonucleotide to attach 2. Calculate the required number of moles of oligonucleotide needed to conjugate to the particles by multiplying the total nanoparticle surface area available for reaction by the expected surface density of nanoparticle-bound oligonucleotide as follows:
where A n is the surface area of the nanoparticle, c n is the concentration of the nanoparticle solution (step 1, in nanoparticles per liter), D o is the oligonucleotide density on each particle (∼35 pmol oligonucleotide/cm 2 ), V is the volume of nanoparticle solution (in L), and r is the radius of the nanoparticles.
The value used for D o is based on Demers et al. (2000); see Background Information for more details. As an example of how this equation might be used, the amount of disulfideterminated oligonucleotide needed to functionalize 5 mL of a 17-nM solution of 13-nm-diameter gold nanoparticles would be:
Conjugate nanoparticles and oligonucleotide
3. To the solution of gold nanoparticles, add an amount of oligonucleotide solution containing 1.5 times the moles of oligonucleotide calculated in step 2 (i.e., a 0.5-molar excess).
The volume of nanoparticle solution is not critical; volumes from microliters to hundreds of milliliters can be used.
4. Rotate the solution 16 hr at room temperature on an orbital shaker at low speed (<1 Hz).
This step works best if conducted in a stoppered, glass container that has been covered to prevent unnecessary exposure to light.
5. Add 0.125 vol each of 1 M NaCl and 0.1 M sodium phosphate buffer (0.1 M NaCl and 10 mM phosphate buffer final). Rotate at low speed for 24 hr at room temperature. 
For larger particles (i.e., >20 nm diameter), the synthesis may be more successful if the transition from pure water to salt solution is made gradually, with multiple small additions of NaCl and buffer solutions.
Isolate conjugates
6. Use a benchtop or high-speed centrifuge to centrifuge the suspension to form a red oil of nanoparticles beneath a clear solution of excess oligonucleotide. Choose (or interpolate) the speed and duration of centrifugation from 
SUPPORT PROTOCOL
SYNTHESIS OF AQUEOUS CITRATE-PROTECTED GOLD COLLOID
This protocol describes a simple synthesis of aqueous gold nanoparticles surrounded by shells of coordinated citrate anions. These particles can be used as starting material in Basic Protocols 1 and 2. A variety of simple protocols for synthesizing gold nanoparticles of various sizes has been reported recently (Brown et al., 2000; Jana et al., 2001) . The particles in this protocol are synthesized by reducing hydrogen tetrachloroaurate (HAuCl 4 ) with a citrate salt (Frens, 1973; Grabar et al., 1995) . The protocol typically yields particles with diameters of ∼15 nm and narrow size distributions; however, both particle diameter and size dispersity vary from preparation to preparation. In general, both particle diameter and monodispersity are influenced by the type of reducing agent and gold precursor salt used, the concentrations of these reagents, the reaction temperature and duration, and the postreaction workup. The resulting particle diameters and dispersities can be quantified by transmission electron microscopy and statistical analysis of collections of particles. However, because of the reliability of this protocol, such characterization is not strictly necessary for conjugate synthesis.
Materials
Aqua regia: 3:1 (v/v) concentrated HCl/concentrated HNO 3 1 mM HAuCl 4 (Aldrich) 38.8 mM sodium citrate (Aldrich)
1-L round-bottom flask Reflux condenser Heating mantle 0.45-µm nylon filter CAUTION: Aqua regia is noxious and extremely caustic. Handle with extreme care in a well-ventilated fume hood.
1. Wash a 1-L round-bottom flask, a reflux condenser, and a large stir-bar with first aqua regia and then thoroughly with water.
2. Assemble the glassware on a heating mantle and a magnetic stirrer, and put the stir-bar in the flask.
3. Charge the flask with 500 mL of 1 mM HAuCl 4 and bring the solution to reflux (100°C) with vigorous stirring.
4. Add 50 mL of 38.8 mM sodium citrate all at once. Continue to reflux the solution for 20 min.
The sodium citrate solution should be added to the mixture as rapidly as possible. If the addition is done correctly, the solution should turn from yellow to purple and then to deep red.
5. Cool the solution to room temperature and filter through a 0.45-µm nylon filter.
6. Store the solution at room temperature in a glass container in the dark. (A) Nanoparticle conjugates bearing only one oligonucleotide strand assemble selectively into dimers in the presence of the template. More complex structures can be generated from templates with additional recognition segments. (B) Nanoparticle conjugates bearing many oligonucleotide strands assemble into polymeric macrostructures in the presence of the complementary template. The optical changes associated with this polymeric assembly make this system particularly effective as a colorimetric DNA hybridization sensor.
COMMENTARY Background Information
As suggested above, the structure, stability, and potential uses of the two types of DNAnanoparticle conjugates described here are very different. Particles with a single attached oligonucleotide, synthesized by the method outlined in Basic Protocol 1, are extremely promising for building tailored nanostructures containing just a few predetermined nanoparticle components. For example, Alivisatos and coworkers have selectively synthesized clusters of two and three nanoparticles in high yields by hybridizing the attached strands to a complementary template (Loweth et al., 1999) , as shown in Figure 12 .2.2A. However, the instability of these conjugates to the conditions frequently encountered in DNA hybridization protocols limits their application in DNA sequence analysis and in situ hybridization. In addition, gel electrophoresis will not provide adequate separation of conjugates made with short oligonucleotide sequences (i.e., <50 nucleotides) and even some long ones.
On the other hand, conjugates with a dense layer of attached oligonucleotides, as described in Basic Protocol 2, have been used in homogeneous and heterogeneous schemes for DNA sequence analysis that require flexible control over hybridization conditions. The number of oligonucleotide strands bound to each particle depends on the surface area of the nanoparticles and the length and sequence of the DNA (Demers et al., 2000) . For example, conjugates between 16-nm-diameter particles and thiolmodified 12-mer oligonucleotides were found to bear ∼160 oligonucleotides per particle, but conjugates between the same particles and a 32-mer oligonucleotide bore 70 oligonucleotides per particle (Demers et al., 2000) . It is important to note that not all of these oligonucleotides are available for hybridization to complementary DNA strands, due to steric compression and electrostatic repulsion at the nanoparticle surface (Levicky et al., 1998) . For example, of the 160 12-mer oligonucleotides attached to each 16-nm particle described above, only 6 oligonucleotides (4%) were found to hybridize to complementary oligonucleotides under standard hybridization conditions (Demers et al., 2000) . This fraction can be increased by inserting a noncomplementary "tether" sequence between the thiol group and the intended hybridization sequence; adding a 20-adenine-long tether to the 12-mer increased the hybridization efficiency from 4% to 44%.
Regardless of nanoparticle size, oligonucleotide length or sequence, the highest surface density of nanoparticle-bound oligonucleotides that has been reported is ∼35 pmol/cm 2 (or ∼0.2 oligonucleotides/nm 2 ). This highest value is used as D o in step 2 of Basic Protocol 2 as an estimate of how much DNA will be needed to completely functionalize every particle in solution. If the oligonucleotide being used is particularly dear, the precise density of functionalization can be measured (Demers et al., 2000) and a more accurate value substituted for D o in subsequent preparations.
Because each particle synthesized by this method bears multiple strands and thus multiple opportunities for hybridization, template strands bearing sequences complementary to different particles will typically assemble those particles into macroscopic assemblies, as shown in Figure 12. 2.2B. The dramitic red-toblue color change that accompanies this particle assembly in solution has been used to identify specific DNA target sequences in solution (Elghanian et al., 1997) . In addition, using these conjugates as DNA labels has been found to increase the selectivity of DNA sequence analysis by oligonucleotide arrays (Taton et al., 2000 (Taton et al., , 2001 .
Basic Protocols 1 and 2 describe the reaction of a disulfide-modified oligonucleotide with the nanoparticle surface. Oligonucleotide strands with other types of sulfur modifications, such as alkylthiol and phosphorothioate groups, would also be expected to form stable nanoparticle conjugates. Disulfide-modified starting materials have the advantage that they are stable to long-term storage and that they spontaneously react with the gold nanoparticle surface. (Alkylthiol-modified strands, on the other hand, typically bear trityl protecting groups, which must be removed before reacting with Au.) The reaction of a disulfide-terminated strand actually adds both the oligonucleotide and a mercaptoalcohol molecule to the particle (Figure 12.2.3 ), but this additional group does not appear to affect the stability or physical properties of the conjugates.
Critical Parameters and Troubleshooting
The success of both protocols is somewhat dependent on the sequence used. As noted above, Basic Protocol 1 provides isolatable conjugates only for sequences longer than 50 nucleotides. In addition, secondary structure caused by self-complementarity in the oligonucleotide sequence may result in broadened bands in the preparative agarose gel (and thus poorer separation). Oligonucleotides shorter than seven nucleotides will generally fail to provide stable conjugates by Basic Protocol 2. In addition, guanosine-rich sequences also fail to form stable conjugates by this method. Conjugates synthesized by Basic Protocol 2 are stable to storage over very long periods of time, but bacterial growth and degradation of hybridization activity have been observed in conjugate solutions that did not contain sodium azide as a preservative. Conjugates made from particles >10 nm may settle from solution with time, but can easily be resuspended by swirling the conjugate solution.
Anticipated Results
Basic Protocols 1 and 2 both yield red solutions of nanoparticle conjugates in which the hybridization properties of the attached oligonucleotide are fully active. This can be readily confirmed by adding a fluorescently labeled, complementary oligonucleotide to the conjugate solution; gold nanoparticles are exceptional quenchers of fluorescence (Gersten and Nitzan, 1981) , and hybridization of the two components leads to a significant decrease in the solution fluorescence. The conjugates can also be analyzed by transmission electron microscopy or by dynamic light scattering to confirm particle sizes and size distributions.
Time Considerations
If the disulfide-modified oligonucleotide and nanoparticle solution are prepared or purchased in advance, then conjugates made by either protocol can easily be prepared and isolated within 3 days.
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